Embecta (EMBC) Share-based Compensation (2020 - 2026)
Embecta (EMBC) posted Share-based Compensation of -$1.0 million for Q1 2026, down 116.95% sequentially from $5.9 million in Q4 2025, and down 211.11% YoY from $900000.0 in Q1 2025.
Embecta (EMBC) Share-based Compensation (2020 - 2026) Analysis & Trends
Embecta has reported Share-based Compensation for 7 years, with the latest figure at -$1.0 million in Q1 2026.
- Quarterly Share-based Compensation fell 211.11% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.9 million (up 551.02% YoY) and the FY2025 annual result came in at $31.6 million, up 953.33% from the prior year.
- Share-based Compensation eased to -$1.0 million in Q1 2026 per EMBC's latest filing, from $5.9 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $17.5 million in Q2 2025 and troughed at -$17.1 million in Q3 2024.
- A 5-year average of $2.3 million and a median of $900000.0 in 2025 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 4250.0% in 2024, down 8650.0% in 2024.
- Over 5 years, Share-based Compensation stood at $2.8 million in 2022, then surged by 160.71% to $7.3 million in 2023, then slumped by 49.32% to $3.7 million in 2024, then surged by 59.46% to $5.9 million in 2025, then tumbled by 116.95% to -$1.0 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered -$1.0 million, $5.9 million, and $9.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.20 Bn | 128.98 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.40 Bn | 51.54 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.70 Bn | 34.35 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.66 Bn | 32.19 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 29.15 Bn | 26.47 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.36 Bn | 14.96 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Embecta | 300.29 Mn | 82.09 Mn | 153.30 Mn | 4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.20 Mn |
| Jun 30, 2026 | 4.20 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 9.50 Mn |
| Sep 30, 2025 | 9.50 Mn |
| Jun 30, 2025 | 17.50 Mn |
| Jun 30, 2025 | 17.50 Mn |
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 3.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | -17.10 Mn |
| Sep 30, 2024 | -17.10 Mn |
| Jun 30, 2024 | 17.40 Mn |
| Jun 30, 2024 | 17.40 Mn |
| Mar 31, 2024 | -4.60 Mn |
| Mar 31, 2024 | -4.60 Mn |